Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > VeruTEK Technologies Announces $6 Million in Equity Financing

Abstract:
VeruTEK Technologies, Inc. (VTKT.OB), a provider of nanotechnology-based green chemistry solutions that eliminate the toxic and harmful effects of chemicals present in the environment, announced the completion of a private placement of equity for approximately $6 million before fees and expenses. The Company intends to use the net proceeds of this offering to broaden market awareness and drive further adoption of its green chemistry solutions. In addition, the Company will use funding for general corporate purposes, including capital expenditures and working capital.

VeruTEK Technologies Announces $6 Million in Equity Financing

BLOOMFIELD, CT | Posted on May 15th, 2008

The $6 million offering was for the sale of approximately 2.8 million units. Each unit was purchased for $2.20 and included two shares of common stock and one warrant. Each warrant allows investors to purchase an additional share of common stock at an exercise price of $1.30 per share and can be exercised for a period of five years.

Needham & Company, LLC acted as sole placement agent in this offering.

The securities described in this announcement have not been registered under the Securities Act of 1933, as amended, or any state securities of "blue sky" laws, and the securities may not be offered or sold absent registration or an applicable exemption from registration requirements. This press release does not and shall not constitute an offer to sell or the solicitation of an offer to buy securities.

####

About VeruTEK Technologies, Inc.
VeruTEK Technologies, Inc. (VTKT.OB) develops, formulates and markets, proprietary patent-pending green chemistry solutions for a number of applications including the remediation of surface and subsurface soil and groundwater contamination. VeruTEK provides clean, green and sustainable solutions for many cases of environmental contamination.

Safe Harbor Statement

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties including, but not limited to, the risks associated with the events described in this press release, future development of VeruTEK's products, and other risks identified in VeruTEK's filings with the Securities and Exchange Commission. Further information on risks faced by VeruTEK are detailed under the caption "Risk Factors" in VeruTEK's Annual Report on Form 10-KSB for the year ended December 31, 2007 and our subsequent Quarterly Reports on Form 10-Q. These filings are available on a website maintained by the Securities and Exchange Commission at http://www.sec.gov. The information contained in this press release is accurate as of the date indicated. Actual results, events or performance may differ materially. VeruTEK undertakes no obligation to publicly release the result of any revision to these forward- looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

For more information, please click here

Contacts:
VeruTEK Technologies, Inc.
Jim Carini
312-953-8319

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Light-powered gyroscope is world's smallest: Promises a powerful spin on navigation April 1st, 2015

Nanion Technologies Appoints James Costantin as Director of Customer Relations: Nanion is pleased to announce the appointment of Dr. James Costantin as Director of Customer Relations at Nanion Technologies Inc. March 31st, 2015

New Applications Brochure on Complex Motion Control Systems for Scientific Research March 31st, 2015

Nanomedicine shines light on combined force of nanomedicine and regenerative medicine March 31st, 2015

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Hong Kong Investors Bullish on Dais Analytic Invest $5.75M, Provide $60M Contract, and Create New Joint Venture Company March 26th, 2015

Harris & Harris Group Reports Financial Statements as of December 31, 2014 and Posts Annual Letter to Shareholders on Website March 17th, 2015

Silicon Catalyst Announces Partnership With imec to Support Semiconductor Start-Ups February 23rd, 2015

Ligar secures investment from Wallace Corporation to commercialise polymers that pick out good and bad molecules: Ground-breaking science innovation removes molecules in the wrong place from liquids February 15th, 2015

Announcements

Light-powered gyroscope is world's smallest: Promises a powerful spin on navigation April 1st, 2015

Prototype 'nanoneedles' generate new blood vessels in mice: Scientists have developed tiny 'nanoneedles' that have successfully prompted parts of the body to generate new blood vessels, in a trial in mice March 31st, 2015

Super sensitive measurement of magnetic fields March 31st, 2015

Nanomedicine pioneer Mauro Ferrari at ETH Zurich March 31st, 2015

Environment

Young NTU Singapore spin-off clinches S$4.3 million joint venture with Chinese commercial giant March 23rd, 2015

New processing technology converts packing peanuts to battery components March 22nd, 2015

EU Funded PCATDES Project has completed its half-period with success March 19th, 2015

Are current water treatment methods sufficient to remove harmful engineered nanoparticle? March 10th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE